Skip to main content

Advertisement

Table 1 Clinical features of the subjects included in the study

From: Polymorphism in asparagine synthetase is associated with overall survival of hepatocellular carcinoma patients

A. Realtime PCR Study
  Non-HBV controls n = 70 CHB patients n = 77 HCC patients n = 90
Age, y mean ± SD 48.2 ± 7.5 49.1 ± 10.1 50.3 ± 9.5
Gender, n. (%)
 Male 39(55.7) 43(55.8) 50(55.6)
 Famale 31(44.3) 34(44.2) 40(44.4)
Smoking, n. (%)
 Yes 30(42.9) 45(58.4) 55(61.1)
 No 40(57.1) 32(41.6) 35(38.9)
Drinking, n. (%)
 Yes 33(47.1) 50(64.9) 73(81.1)
 No 37(52.9) 27(35.1) 17(18.9)
B. Case–control Study
  HCC CHB P
Number 337 310  
Age, y mean ± SD 44.7 ± 11.0 44.3 ± 12.3 0.67
Gender (male/female) 298/39 254/56 0.02
Smoking (Yes/No) 141/192 128/182 0.79
Drinking (Yes/No) 98/239 92/218 0.87
Family history of HCC (Yes/No) 58/279 14/296 <0.001
  1. HCC hepatocellular carcinoma, CHB chronic hepatitis B